We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Molina Healthcare Inc | NYSE:MOH | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.68 | 0.20% | 339.55 | 342.505 | 336.37 | 339.70 | 392,468 | 01:00:00 |
Raises Full Year 2019 Earnings Guidance
Molina Healthcare, Inc. (NYSE: MOH) today reported net income for the third quarter of 2019 of $175 million, or $2.75 per diluted share, compared to net income of $197 million, or $2.90 per diluted share, in the third quarter of 2018. Financial results for the third quarter of 2019 are summarized below:
Three Months Ended
Nine Months Ended
September 30,
September 30,
2019
2018
2019
2018
(In millions, except per share results)
Premium Revenue
$4,084
$4,337
$12,085
$13,174
Total Revenue
$4,243
$4,697
$12,555
$14,226
Pre-Tax Income
$233
$259
$750
$743
Net Income
$175
$197
$569
$506
EPS - Diluted
$2.75
$2.90
$8.80
$7.60
MCR
86.3%
87.4%
85.7%
86.2%
G&A Ratio
7.6%
6.6%
7.6%
7.0%
Pre-Tax Margin
5.5%
5.5%
6.0%
5.2%
Effective Tax Rate
24.7%
24.0%
24.1%
31.9%
After-Tax Margin
4.1%
4.2%
4.5%
3.6%
Highlights include:
“We are pleased with our performance this quarter as we sustained our margin profile, produced significant excess capital, and increased our full year 2019 guidance,” said Joe Zubretsky, president and CEO. “We have accomplished this in the backdrop of commencing our pivot to growth.”
Premium Revenue
Premium revenue for the third quarter of 2019 decreased 5.8% to $4.1 billion compared to $4.3 billion in the third quarter of 2018, which was in line with the Company’s expectations.
For the nine months ended September 30, 2019, premium revenue decreased 8.3% to $12.1 billion, from $13.2 billion for the comparable period in 2018. In both periods, the lower premium revenue is primarily a result of previously announced losses of Medicaid membership in New Mexico and Florida.
Medical Care Ratio
The consolidated MCR for the third quarter of 2019 was 86.3% compared to 87.4% in the third quarter of 2018. Prior period reserve development in the quarter was negligible.
The MCR for the nine months ended September 30, 2019, improved to 85.7% compared to 86.2% for the comparable period in 2018, due to a combination of the following:
General and Administrative Expense Ratio
The general and administrative expenses were 7.6% of total revenues in the third quarter of 2019 compared to 6.6% in the third quarter of 2018.
For the nine months ended September 30, 2019, the G&A ratio was 7.6% compared to 7.0% in the comparable prior-year period. In both periods, the year-over-year increases are due mainly to the year-over-year decline in total revenues.
Interest Expense
Interest expense was $22 million in the third quarter of 2019 compared to $26 million in the third quarter of 2018. The decline was due to continued repayment of convertible notes.
Other Expenses
The third quarter results included a $2 million charge on the repayment of convertible notes, resulting in a $0.03 net loss per diluted share.
Balance Sheet
Cash and investments at the parent company amounted to $796 million as of September 30, 2019, compared to $467 million as of June 30, 2019.
During the third quarter of 2019, the parent company received $430 million of dividends from the regulated health plan subsidiaries.
The Company repaid $55 million of principal on the convertible notes during the quarter, and $240 million since the beginning of the year. The impact of capital deployment actions in the quarter resulted in lower interest expense, a slight loss on repayment of the convertible notes, and a lower share count.
Cash Flow
Operating cash flows for the nine months ended September 30, 2019, amounted to $398 million and were higher compared to the nine months ended September 30, 2018, primarily due to the normal fluctuations of working capital.
Outlook
The Company raised its full year 2019 earnings guidance range to $11.30 - $11.55 per diluted share, from previously issued guidance of $11.20 - $11.50.
Guidance is based on the following:
October 29, 2019 (1)
July 30, 2019 (1)
(current)
(previous)
Premium revenue
$16.1B
$16.1B
Medicaid
$12.4B
$12.3B
Medicare
$2.2B
$2.2B
Marketplace
$1.5B
$1.6B
Premium tax revenue
$565M
$450M
Investment income and other revenue
$135M
$115M
Total revenue
$16.8B
$16.7B
Medical care costs
$13.8B
$13.8B
General and administrative expenses
$1.3B
$1.3B
Premium tax expenses
$565M
$450M
EBITDA (2)
$1,140M - $1,160M
$1,135M - $1,160M
Depreciation and amortization
$90M
$90M
Interest expense and other expenses, net
$90M
$90M
Income before income taxes
$960M - $980M
$955M - $980M
Net income
$725M - $740M
$725M - $740M
Net income per share
$11.30 - $11.55
$11.20 - $11.50
Diluted weighted average shares
64.2M
64.5M
End-of-year membership:
Medicaid and Medicare
3.1M
3.1M
Marketplace
270K
270K - 280K
Operating Statistics:
Medical care ratio
86%
86%
G&A ratio
7.7%
7.7%
Effective income tax expense rate
24.3%
24.2%
After-tax margin
4.3% - 4.4%
4.2% - 4.4%
Medicaid
3%
3%
Medicare
7%
7%
Marketplace
11%
11%
__________________
(1) All amounts are rounded and approximations. (2) See reconciliation of non-GAAP financial measures at the end of this release.Conference Call
Management will host a conference call and webcast to discuss Molina Healthcare’s third quarter 2019 results at 8:00 a.m. Eastern time on Wednesday, October 30, 2019. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 5680857. A telephonic replay of the conference call will be available through Wednesday, November 6, 2019, by dialing (877) 344-7529 and entering confirmation number 10135133. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30‑day online replay will be available approximately an hour following the conclusion of the live broadcast.
About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 3.3 million members as of September 30, 2019. For more information about Molina Healthcare, please visit molinahealthcare.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This earnings release contains forward-looking statements regarding the Company’s revised 2019 guidance, as well as its plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those risks and uncertainties are discussed in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and the section entitled “Forward-Looking Statements” in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2019.
These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of October 29, 2019, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended
Nine Months Ended
September 30,
September 30,
2019
2018
2019
2018
(In millions, except per-share amounts)
Revenue:
Premium revenue
$
4,084
$
4,337
$
12,085
$
13,174
Premium tax revenue
119
110
367
320
Health insurer fees reimbursed
—
83
—
248
Service revenue
—
130
—
391
Investment income and other revenue
40
37
103
93
Total revenue
4,243
4,697
12,555
14,226
Operating expenses:
Medical care costs
3,523
3,790
10,360
11,362
General and administrative expenses
323
311
953
998
Premium tax expenses
119
110
367
320
Health insurer fees
—
87
—
261
Depreciation and amortization
21
25
68
76
Restructuring costs
—
5
5
38
Cost of service revenue
—
111
—
349
Total operating expenses
3,986
4,439
11,753
13,404
Gain on sale of subsidiary
—
37
—
37
Operating income
257
295
802
859
Other expenses, net:
Interest expense
22
26
67
91
Other expenses (income), net
2
10
(15
)
25
Total other expenses, net
24
36
52
116
Income before income tax expense
233
259
750
743
Income tax expense
58
62
181
237
Net income
$
175
$
197
$
569
$
506
Net income per share, diluted
$
2.75
$
2.90
$
8.80
$
7.60
Diluted weighted average shares outstanding
63.6
67.9
64.6
66.6
Operating Statistics:
Medical care ratio
86.3
%
87.4
%
85.7
%
86.2
%
G&A ratio
7.6
%
6.6
%
7.6
%
7.0
%
Premium tax ratio
2.8
%
2.5
%
2.9
%
2.4
%
Effective income tax rate
24.7
%
24.0
%
24.1
%
31.9
%
After-tax margin
4.1
%
4.2
%
4.5
%
3.6
%
Medicaid
3.4
%
2.8
%
3.1
%
2.0
%
Medicare
6.4
%
1.4
%
7.0
%
3.7
%
Marketplace
8.1
%
15.3
%
11.9
%
16.7
%
CONSOLIDATED BALANCE SHEETS
September 30,
December 31,
2019
2018
Unaudited
(Dollars in millions, except per-share amounts)
ASSETS
Current assets:
Cash and cash equivalents
$
2,679
$
2,826
Investments
1,757
1,681
Receivables
1,280
1,330
Prepaid expenses and other current assets
140
149
Derivative asset
21
476
Total current assets
5,877
6,462
Property, equipment, and capitalized software, net
379
241
Goodwill and intangible assets, net
176
190
Restricted investments
79
120
Deferred income taxes
82
117
Other assets
108
24
$
6,701
$
7,154
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims and benefits payable
$
1,975
$
1,961
Amounts due government agencies
612
967
Accounts payable and accrued liabilities
478
390
Deferred revenue
207
211
Current portion of long-term debt
15
241
Derivative liability
21
476
Total current liabilities
3,308
4,246
Long-term debt
1,239
1,020
Finance lease liabilities
233
197
Other long-term liabilities
90
44
Total liabilities
4,870
5,507
Stockholders’ equity:
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 63 million shares at September 30, 2019 and 62 million shares at December 31, 2018
—
—
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding
—
—
Additional paid-in capital
160
643
Accumulated other comprehensive income (loss)
5
(8
)
Retained earnings
1,666
1,012
Total stockholders’ equity
1,831
1,647
$
6,701
$
7,154
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
Nine Months Ended
September 30,
September 30,
2019
2018
2019
2018
(In millions)
Operating activities:
Net income
$
175
$
197
$
569
$
506
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization
21
31
68
104
Deferred income taxes
(12
)
(26
)
7
(32
)
Share-based compensation
10
7
29
20
Amortization of convertible senior notes and finance lease liabilities
1
5
5
18
Loss (gain) on debt repayment
2
10
(15
)
25
Gain on sale of subsidiary
—
(37
)
—
(37
)
Non-cash restructuring costs
—
—
—
17
Other, net
(8
)
2
(5
)
6
Changes in operating assets and liabilities:
Receivables
(41
)
(192
)
50
(507
)
Prepaid expenses and other current assets
(24
)
64
(6
)
(117
)
Medical claims and benefits payable
208
123
14
(144
)
Amounts due government agencies
(372
)
(716
)
(355
)
(511
)
Accounts payable and accrued liabilities
98
49
37
398
Deferred revenue
177
(13
)
(4
)
(55
)
Income taxes
7
(9
)
4
118
Net cash provided by (used in) operating activities
242
(505
)
398
(191
)
Investing activities:
Purchases of investments
(776
)
(288
)
(1,938
)
(1,202
)
Proceeds from sales and maturities of investments
1,099
735
1,890
2,070
Purchases of property, equipment, and capitalized software
(10
)
(10
)
(30
)
(24
)
Other, net
—
(14
)
(2
)
(23
)
Net cash provided by (used in) investing activities
313
423
(80
)
821
Financing activities:
Repayment of principal amount of 1.125% Convertible Notes
(55
)
(140
)
(240
)
(236
)
Cash paid for partial settlement of 1.125% Conversion Option
(105
)
(343
)
(578
)
(477
)
Cash received for partial termination of 1.125% Call Option
105
343
578
477
Cash paid for partial termination of 1.125% Warrants
(90
)
(306
)
(514
)
(419
)
Proceeds from borrowings under Term Loan Facility
—
—
220
—
Repayment of Credit Facility
—
—
—
(300
)
Repayment of 1.625% Convertible Notes
—
(64
)
—
(64
)
Other, net
(3
)
1
24
7
Net cash used in financing activities
(148
)
(509
)
(510
)
(1,012
)
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents
407
(591
)
(192
)
(382
)
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period
2,327
3,499
2,926
3,290
Cash, cash equivalents, and restricted cash and cash equivalents at end of period
$
2,734
$
2,908
$
2,734
$
2,908
HEALTH PLANS SEGMENT MEMBERSHIP
September 30,
2019
December 31,
2018
September 30,
2018
Ending Membership by Government Program:
TANF and CHIP
1,993,000
2,295,000
2,436,000
Medicaid Expansion
598,000
660,000
664,000
ABD
364,000
406,000
415,000
Total Medicaid
2,955,000
3,361,000
3,515,000
MMP - Integrated
58,000
54,000
55,000
Medicare Special Needs Plans
44,000
44,000
45,000
Total Medicare
102,000
98,000
100,000
Total Medicaid and Medicare
3,057,000
3,459,000
3,615,000
Marketplace
289,000
362,000
384,000
3,346,000
3,821,000
3,999,000
Ending Membership by Health Plan:
California
580,000
608,000
623,000
Florida (1)
136,000
313,000
395,000
Illinois
224,000
224,000
223,000
Michigan
361,000
383,000
394,000
New Mexico (1)
24,000
222,000
234,000
Ohio
292,000
302,000
315,000
Puerto Rico
186,000
252,000
320,000
South Carolina
134,000
120,000
117,000
Texas
350,000
423,000
436,000
Washington
818,000
781,000
770,000
Other (2)
241,000
193,000
172,000
3,346,000
3,821,000
3,999,000
__________________
(1) The Company’s Medicaid contracts in New Mexico and in all but two regions in Florida terminated in late 2018 and early 2019. During 2019, the Company continues to serve Medicare and Marketplace members in both Florida and New Mexico, as well as Medicaid members in two regions in Florida. (2) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.UNAUDITED SELECTED FINANCIAL DATA (In millions, except percentages and per-member per-month amounts) HEALTH PLANS SEGMENT FINANCIAL DATA — BY GOVERNMENT PROGRAM
Member
Months (1)
Premium Revenue
Medical Care Costs
MCR (2)
Medical
Margin
Total
PMPM
Total
PMPM
Three Months Ended September 30, 2019
TANF and CHIP
6.0
$
1,225
$
202.46
$
1,071
$
176.88
87.4
%
$
154
Medicaid Expansion
1.8
696
385.63
622
345.25
89.5
74
ABD
1.1
1,247
1,136.67
1,097
1,000.56
88.0
150
Total Medicaid
8.9
3,168
353.81
2,790
311.70
88.1
378
MMP
0.2
399
2,328.70
345
2,010.50
86.3
54
Medicare
0.1
160
1,230.01
134
1,029.75
83.7
26
Total Medicare
0.3
559
1,854.96
479
1,587.61
85.6
80
Total Medicaid and Medicare
9.2
3,727
402.76
3,269
353.31
87.7
458
Marketplace
0.9
357
410.23
254
292.21
71.2
103
10.1
$
4,084
$
403.40
$
3,523
$
348.06
86.3
%
$
561
Three Months Ended September 30, 2018
TANF and CHIP
7.4
$
1,379
$
187.03
$
1,228
$
166.41
89.0
%
$
151
Medicaid Expansion
2.0
671
333.11
640
317.62
95.3
31
ABD
1.2
1,322
1,054.92
1,186
946.38
89.7
136
Total Medicaid
10.6
3,372
316.86
3,054
286.86
90.5
318
MMP
0.2
353
2,159.72
323
1,981.45
91.7
30
Medicare
0.1
156
1,157.71
121
895.25
77.3
35
Total Medicare
0.3
509
1,706.95
444
1,490.63
87.3
65
Total Medicaid and Medicare
10.9
3,881
354.70
3,498
319.63
90.1
383
Marketplace
1.2
456
394.02
292
252.61
64.1
164
12.1
$
4,337
$
358.46
$
3,790
$
313.23
87.4
%
$
547
Nine Months Ended September 30, 2019
TANF and CHIP
18.3
$
3,594
$
196.01
$
3,141
$
171.30
87.4
%
$
453
Medicaid Expansion
5.4
2,055
380.08
1,810
334.85
88.1
245
ABD
3.3
3,590
1,097.94
3,200
978.64
89.1
390
Total Medicaid
27.0
9,239
342.03
8,151
301.77
88.2
1,088
MMP
0.5
1,193
2,368.38
1,034
2,051.90
86.6
159
Medicare
0.4
489
1,270.32
399
1,037.24
81.7
90
Total Medicare
0.9
1,682
1,892.63
1,433
1,612.29
85.2
249
Total Medicaid and Medicare
27.9
10,921
391.44
9,584
343.53
87.8
1,337
Marketplace
2.8
1,164
414.17
776
276.28
66.7
388
30.7
$
12,085
$
393.52
$
10,360
$
337.37
85.7
%
$
1,725
Nine Months Ended September 30, 2018
TANF and CHIP
22.3
$
4,145
$
186.12
$
3,705
$
166.35
89.4
%
$
440
Medicaid Expansion
6.1
2,184
359.37
1,957
322.01
89.6
227
ABD
3.7
3,864
1,034.25
3,550
950.11
91.9
314
Total Medicaid
32.1
10,193
317.70
9,212
287.10
90.4
981
MMP
0.5
1,077
2,173.90
941
1,899.26
87.4
136
Medicare
0.4
470
1,171.59
385
959.54
81.9
85
Total Medicare
0.9
1,547
1,725.71
1,326
1,479.06
85.7
221
Total Medicaid and Medicare
33.0
11,740
355.96
10,538
319.50
89.8
1,202
Marketplace
3.8
1,434
379.91
824
218.44
57.5
610
36.8
$
13,174
$
358.42
$
11,362
$
309.12
86.2
%
$
1,812
__________________
(1) A member month is defined as the aggregate of each month’s ending membership for the period presented. (2) The MCR represents medical costs as a percentage of premium revenue.HEALTH PLANS SEGMENT FINANCIAL DATA — MEDICAID AND MEDICARE
Member
Months
Premium Revenue
Medical Care Costs
MCR
Medical
Margin
Total
PMPM
Total
PMPM
Three Months Ended September 30, 2019
California
1.6
$
510
$
315.90
$
423
$
261.97
82.9
%
$
87
Florida
0.3
130
436.99
127
427.80
97.9
3
Illinois
0.7
257
383.41
232
347.28
90.6
25
Michigan
1.1
401
373.01
332
307.97
82.6
69
Ohio
0.9
615
687.38
563
628.98
91.5
52
Puerto Rico
0.6
117
209.25
102
182.53
87.2
15
South Carolina
0.4
151
379.20
138
347.23
91.6
13
Texas
0.7
592
912.76
540
833.51
91.3
52
Washington
2.3
643
269.52
570
238.55
88.5
73
Other (1) (2)
0.6
311
437.60
242
341.29
78.0
69
9.2
$
3,727
$
402.76
$
3,269
$
353.31
87.7
%
$
458
Three Months Ended September 30, 2018
California
1.7
$
435
$
249.00
$
446
$
255.22
102.5
%
$
(11
)
Florida
1.0
388
363.16
362
339.33
93.4
26
Illinois
0.7
207
312.72
182
274.98
87.9
25
Michigan
1.1
397
350.05
321
282.49
80.7
76
New Mexico (2)
0.6
304
471.66
275
426.69
90.5
29
Ohio
0.9
584
624.84
532
568.93
91.1
52
Puerto Rico
1.0
179
189.65
162
171.96
90.7
17
South Carolina
0.4
124
354.53
112
318.56
89.9
12
Texas
0.7
577
848.47
525
772.14
91.0
52
Washington
2.3
511
226.77
444
197.04
86.9
67
Other (1)
0.5
175
334.29
137
261.49
78.2
38
10.9
$
3,881
$
354.70
$
3,498
$
319.63
90.1
%
$
383
Nine Months Ended September 30, 2019
California
4.9
$
1,508
$
306.96
$
1,286
$
261.76
85.3
%
$
222
Florida
1.0
418
410.71
374
367.95
89.6
44
Illinois
2.0
726
365.35
632
318.26
87.1
94
Michigan
3.3
1,199
370.77
990
305.99
82.5
209
Ohio
2.7
1,835
682.59
1,653
614.89
90.1
182
Puerto Rico
1.8
341
190.42
301
167.98
88.2
40
South Carolina
1.2
427
368.35
378
326.61
88.7
49
Texas
2.0
1,789
910.64
1,623
826.20
90.7
166
Washington
7.1
1,868
261.92
1,691
236.98
90.5
177
Other (1) (2)
1.9
810
402.31
656
325.93
81.0
154
27.9
$
10,921
$
391.44
$
9,584
$
343.53
87.8
%
$
1,337
Nine Months Ended September 30, 2018
California
5.3
$
1,446
$
270.63
$
1,299
$
243.14
89.8
%
$
147
Florida
3.2
1,147
356.15
1,069
331.93
93.2
78
Illinois
1.8
551
308.45
474
265.47
86.1
77
Michigan
3.4
1,161
343.08
983
290.26
84.6
178
New Mexico (2)
2.0
936
469.19
875
438.70
93.5
61
Ohio
2.8
1,670
590.71
1,474
521.26
88.2
196
Puerto Rico
2.9
549
190.34
501
173.83
91.3
48
South Carolina
1.1
369
350.94
323
306.76
87.4
46
Texas
2.1
1,715
831.21
1,554
753.31
90.6
161
Washington
6.8
1,666
245.40
1,544
227.41
92.7
122
Other (1)
1.6
530
323.84
442
269.98
83.4
88
33.0
$
11,740
$
355.96
$
10,538
$
319.50
89.8
%
$
1,202
_______________
(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results. (2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.HEALTH PLANS SEGMENT FINANCIAL DATA — MARKETPLACE
Member
Months
Premium Revenue
Medical Care Costs
MCR
Medical
Margin
Total
PMPM
Total
PMPM
Three Months Ended September 30, 2019
California
0.2
$
57
$
371.07
$
33
$
210.87
56.8
%
$
24
Florida
0.1
41
349.53
25
212.00
60.7
16
Michigan
—
7
431.41
4
289.45
67.1
3
Ohio
—
25
792.96
19
626.30
79.0
6
Texas
0.4
142
351.04
105
257.68
73.4
37
Washington
0.1
45
719.67
33
548.75
76.2
12
Other (1)
0.1
40
480.41
35
408.35
85.0
5
0.9
$
357
$
410.23
$
254
$
292.21
71.2
%
$
103
Three Months Ended September 30, 2018
California
0.2
$
49
$
309.04
$
37
$
235.63
76.2
%
$
12
Florida
0.2
66
548.60
45
362.39
66.1
21
Michigan
—
12
233.51
7
145.13
62.1
5
New Mexico
0.1
28
419.20
18
249.33
59.5
10
Ohio
0.1
27
485.08
18
336.86
69.4
9
Texas
0.6
228
357.54
134
209.80
58.7
94
Washington
—
44
656.70
34
518.75
79.0
10
Other (2)
—
2
NM
(1
)
NM
NM
3
1.2
$
456
$
394.02
$
292
$
252.61
64.1
%
$
164
Nine Months Ended September 30, 2019
California
0.5
$
174
$
364.72
$
101
$
210.76
57.8
%
$
73
Florida
0.4
152
389.44
81
207.22
53.2
71
Michigan
—
27
474.12
15
265.95
56.1
12
Ohio
0.1
79
801.90
53
543.00
67.7
26
Texas
1.3
457
344.19
331
249.44
72.5
126
Washington
0.2
143
744.47
97
509.50
68.4
46
Other (1)
0.3
132
494.59
98
364.71
73.7
34
2.8
$
1,164
$
414.17
$
776
$
276.28
66.7
%
$
388
Nine Months Ended September 30, 2018
California
0.6
$
171
$
326.82
$
89
$
169.98
52.0
%
$
82
Florida
0.5
211
491.13
67
155.24
31.6
144
Michigan
0.1
40
248.24
23
145.38
58.6
17
New Mexico
0.2
93
426.07
55
247.57
58.1
38
Ohio
0.2
84
466.75
58
324.91
69.6
26
Texas
2.0
679
330.92
440
214.65
64.9
239
Washington
0.2
139
654.78
105
497.00
75.9
34
Other (2)
—
17
NM
(13
)
NM
NM
30
3.8
$
1,434
$
379.91
$
824
$
218.44
57.5
%
$
610
__________________
(1) “Other” includes the New Mexico, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results in 2019.(2) “Other” includes the Utah and Wisconsin health plans, where the Company did not participate in the Marketplace in 2018. Therefore, the ratios for 2018 periods are not meaningful (NM).
HEALTH PLANS SEGMENT FINANCIAL DATA — TOTAL
Member
Months
Premium Revenue
Medical Care Costs
MCR
Medical
Margin
Total
PMPM
Total
PMPM
Three Months Ended September 30, 2019
California
1.8
$
567
$
320.67
$
456
$
257.55
80.3
%
$
111
Florida
0.4
171
412.29
152
366.86
89.0
19
Illinois
0.7
257
383.41
232
347.28
90.6
25
Michigan
1.1
408
373.92
336
307.68
82.3
72
Ohio
0.9
640
690.88
582
628.89
91.0
58
Puerto Rico
0.6
117
209.25
102
182.53
87.2
15
South Carolina
0.4
151
379.20
138
347.23
91.6
13
Texas
1.1
734
696.46
645
611.78
87.8
89
Washington
2.4
688
280.85
603
246.36
87.7
85
Other (1) (2)
0.7
351
442.14
277
348.40
78.8
74
10.1
$
4,084
$
403.40
$
3,523
$
348.06
86.3
%
$
561
Three Months Ended September 30, 2018
California
1.9
$
484
$
253.96
$
483
$
253.60
99.9
%
$
1
Florida
1.2
454
382.20
407
341.70
89.4
47
Illinois
0.7
207
312.72
182
274.98
87.9
25
Michigan
1.1
409
345.28
328
276.88
80.2
81
New Mexico (2)
0.7
332
466.63
293
409.68
87.8
39
Ohio
1.0
611
616.95
550
555.83
90.1
61
Puerto Rico
1.0
179
189.65
162
171.96
90.7
17
South Carolina
0.4
124
354.53
112
318.56
89.9
12
Texas
1.3
805
611.01
659
500.14
81.9
146
Washington
2.3
555
239.25
478
206.38
86.3
77
Other (1)
0.5
177
336.18
136
260.19
77.4
41
12.1
$
4,337
$
358.46
$
3,790
$
313.23
87.4
%
$
547
Nine Months Ended September 30, 2019
California
5.4
$
1,682
$
312.08
$
1,387
$
257.25
82.4
%
$
295
Florida
1.4
570
404.81
455
323.37
79.9
115
Illinois
2.0
726
365.35
632
318.26
87.1
94
Michigan
3.3
1,226
372.58
1,005
305.29
81.9
221
Ohio
2.8
1,914
686.80
1,706
612.35
89.2
208
Puerto Rico
1.8
341
190.42
301
167.98
88.2
40
South Carolina
1.2
427
368.35
378
326.61
88.7
49
Texas
3.3
2,246
682.10
1,954
593.50
87.0
292
Washington
7.3
2,011
274.52
1,788
244.10
88.9
223
Other (1) (2)
2.2
942
413.13
754
330.48
80.0
188
30.7
$
12,085
$
393.52
$
10,360
$
337.37
85.7
%
$
1,725
Nine Months Ended September 30, 2018
California
5.9
$
1,617
$
275.64
$
1,388
$
236.61
85.8
%
$
229
Florida
3.7
1,358
372.07
1,136
311.09
83.6
222
Illinois
1.8
551
308.45
474
265.47
86.1
77
Michigan
3.5
1,201
338.83
1,006
283.77
83.7
195
New Mexico (2)
2.2
1,029
464.92
930
419.78
90.3
99
Ohio
3.0
1,754
583.29
1,532
509.52
87.4
222
Puerto Rico
2.9
549
190.34
501
173.83
91.3
48
South Carolina
1.1
369
350.94
323
306.76
87.4
46
Texas
4.1
2,394
581.74
1,994
484.70
83.3
400
Washington
7.0
1,805
257.82
1,649
235.59
91.4
156
Other (1)
1.6
547
334.26
429
262.27
78.5
118
36.8
$
13,174
$
358.42
$
11,362
$
309.12
86.2
%
$
1,812
__________________
(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.
(2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.SELECTED FINANCIAL DATA
The following table provides details of the Company’s medical care costs for the periods indicated:
Three Months Ended September 30,
2019
2018
Amount
PMPM
% of
Total
Amount
PMPM
% of
Total
Fee for service
$
2,685
$
265.12
76.2
%
$
2,865
$
236.74
75.6
%
Pharmacy
412
40.74
11.7
495
40.90
13.1
Capitation
283
28.01
8.0
297
24.52
7.8
Other
143
14.19
4.1
133
11.07
3.5
$
3,523
$
348.06
100.0
%
$
3,790
$
313.23
100.0
%
Nine Months Ended September 30,
2019
2018
Amount
PMPM
% of
Total
Amount
PMPM
% of
Total
Fee for service
$
7,793
$
253.77
75.2
%
$
8,471
$
230.46
74.6
%
Pharmacy
1,254
40.83
12.1
1,645
44.76
14.5
Capitation
856
27.88
8.3
891
24.23
7.8
Other
457
14.89
4.4
355
9.67
3.1
$
10,360
$
337.37
100.0
%
$
11,362
$
309.12
100.0
%
The following table provides details of the Company’s medical claims and benefits payable as of the dates indicated:
September 30,
December 31,
2019
2018
Fee-for-service claims incurred but not paid (IBNP)
$
1,424
$
1,562
Pharmacy payable
128
115
Capitation payable
57
52
Other (1)
366
232
$
1,975
$
1,961
______________________
(1) “Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s consolidated statements of income. As of September 30, 2019 and December 31, 2018, the Company had recorded non-risk provider payables of approximately $239 million and $107 million, respectively.CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE (Dollars in millions)
The Company’s claims liability includes a provision for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which the original estimate of claims and benefits payable at the beginning of the period was more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:
Nine Months Ended
Year Ended
September 30,
Dec. 31,
2018
2019
2018
Medical claims and benefits payable, beginning balance
$
1,961
$
2,192
$
2,192
Components of medical care costs related to:
Current period
10,613
11,670
15,478
Prior period (1)
(253
)
(308
)
(341
)
Total medical care costs
10,360
11,362
15,137
Change in non-risk and other provider payables
131
60
13
Payments for medical care costs related to:
Current period
8,996
9,866
13,671
Prior period
1,481
1,706
1,710
Total paid
10,477
11,572
15,381
Medical claims and benefits payable, ending balance
$
1,975
$
2,042
$
1,961
Days in claims payable, fee for service (2)
50
53
53
______________________
(1) The September 30, 2018, and December 31, 2018, amounts include the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.
(2) Claims payable includes primarily IBNP. It also includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $42 million, $34 million and $43 million, as of September 30, 2019, September 30, 2018, and December 31, 2018, respectively.SUMMARY OF NON-RUN RATE ITEMS AFFECTING CURRENT QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS (In millions, except per diluted share amounts)
The table below summarizes the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations. The individual items presented below increase (decrease) income before income tax expense.
Three Months Ended September 30,
Nine Months Ended September 30,
2019
2018
2019
2018
Amount
Per
Diluted
Share (1)
Amount
Per
Diluted
Share (1)
Amount
Per
Diluted
Share (1)
Amount
Per
Diluted
Share (1)
(Loss) gain on debt repayment
$
(2
)
$
(0.03
)
$
(10
)
$
(0.12
)
$
15
$
0.18
$
(25
)
$
(0.33
)
Restructuring costs
—
—
(5
)
(0.06
)
(5
)
(0.06
)
(38
)
(0.45
)
Gain on sale of subsidiary
—
—
37
0.42
—
—
37
0.43
$
(2
)
$
(0.03
)
$
22
$
0.24
$
10
$
0.12
$
(26
)
$
(0.35
)
______________________
(1) Except for permanent differences between GAAP and tax (such as certain expenses that are not deductible for tax purposes), per diluted share amounts are generally calculated at the statutory income tax rate of 22.6% and 22% for 2019 and 2018, respectively.
NON-GAAP FINANCIAL MEASURES
The Company uses non-generally accepted accounting principles, or non-GAAP, financial measures as supplemental metrics in evaluating the Company’s financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures. See further information regarding non-GAAP measures below the tables.
Three Months Ended
Nine Months Ended
September 30,
September 30,
2019
2018
2019
2018
Net income
$
175
$
197
$
569
$
506
Adjustments:
Depreciation, and amortization of intangible assets and capitalized software
21
28
68
95
Interest expense
22
26
67
91
Income tax expense
58
62
181
237
EBITDA
$
276
$
313
$
885
$
929
Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:
Earnings before interest, taxes, depreciation and amortization (“EBITDA”): Net income on a GAAP basis less depreciation, and amortization of intangible assets and capitalized software, interest expense and income tax expense. The Company believes that EBITDA is helpful in assessing the Company’s ability to meet the cash demands of its operating units.
Three Months Ended September 30,
Nine Months Ended September 30,
2019
2018
2019
2018
Amount
Per
Diluted
Share
Amount
Per
Diluted
Share
Amount
Per
Diluted
Share
Amount
Per
Diluted
Share
Net income
$
175
$
2.75
$
197
$
2.90
$
569
$
8.80
$
506
$
7.60
Adjustment:
Amortization of intangible assets
4
0.07
6
0.08
13
0.21
16
0.23
Income tax effect (1)
(1
)
(0.02
)
(2
)
(0.01
)
(3
)
(0.05
)
(4
)
(0.05
)
Adjustment, net of tax effect
3
0.05
4
0.07
10
0.16
12
0.18
Adjusted net income
$
178
$
2.80
$
201
$
2.97
$
579
$
8.96
$
518
$
7.78
________________________
(1) Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively.
Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:
Adjusted net income: Net income on a GAAP basis less amortization of intangible assets, net of income tax effect calculated at the statutory tax rate. The Company believes that adjusted net income is helpful in assessing the Company’s financial performance exclusive of the non-cash impact of the amortization of purchased intangibles.
Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.
2019 REVISED GUIDANCE
Reconciliation of Non-GAAP Financial Measures
Low End
High End
(In millions)
Net income
$
725
$
740
Adjustments:
Depreciation, and amortization of intangible assets and capitalized software
90
90
Interest expense
90
90
Income tax expense
235
240
EBITDA
$
1,140
$
1,160
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005966/en/
Investor Contact: Julie Trudell, Julie.Trudell@molinahealthcare.com, 562-912-6720
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588
1 Year Molina Healthcare Chart |
1 Month Molina Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions